Browsing: Weight Loss

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. 

GLP-1 coverage trends force Canadian benefits insurers to rethink plan design | Insurance Business

India, July 9, 2026 /PRNewswire/ — India is approaching a pivotal moment in the evolution of obesity and metabolic health management. As awareness grows among healthcare professionals and patients alike, the obesity care ecosystem is rapidly transitioning from reactive treatment toward proactive and long-term disease management

SINGAPORE, July 8, 2026 /PRNewswire/ — Novo Nordisk announced an update to the Singapore label for semaglutide, approved in Singapore as Wegovy® (semaglutide) injection, incorporating clinical evidence from the STEP UP trial in adults living with obesity without diabetes. In the trial, which evaluated a higher dose of semaglutide (7.2 mg), up to one in three…

New research indicates that Wegovy pills are as effective as their injectable counterparts for weight loss, though they may not deliver the same heart health benefits

The monsoon season brings much-needed respite from the scorching summer heat, but it also increases the risk of infections, stomach illnesses, and seasonal flu among children. With the change in temperatures, increased humidity and the growth of pathogens like bacteria and viruses, children become easily vulnerable to illnesses during this season. While parents need to know…

This study aimed to determine the independent and interactive effects of changes in alcohol intake and body weight on hepatic steatosis remission in elderly patients with Metabolic Alcohol-associated Liver Disease (MetALD)

Most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, despite patients achieving substantial weight loss, a study has found

New research indicates that Wegovy pills are as effective as their injectable counterparts for weight loss, though they may not deliver the same heart health benefits

Ga. (WTOC) – GLP-1 medications became available to some Medicare Part D patients on July 1, expanding access to the once-weekly weight loss drug